Video Experimental Relacionado
Updated: Jul 9, 2026
12:59
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
Una dieta baja en sodio corrige el defecto en la respuesta beta-adrenérgica en sujetos mayores
1Department of Medicine, University of Western Ontario, London, Canada.
Circulation
|February 1, 1992
Resumen
Una dieta baja en sodio mejora la respuesta beta-adrenérgica en adultos mayores, mejorando la función vascular y linfocítica. Este cambio en la dieta puede ayudar a regular la presión arterial y el tono vascular en los ancianos.
Área de la Ciencia:
- Fisiología cardiovascular fisiología cardiovascular.
- Gerontología Gerontología.
- Farmacología Farmacología.
Sus antecedentes:
- El envejecimiento está asociado con una menor capacidad de respuesta de los receptores beta-adreno, una anomalía cardiovascular clave.
- La restricción dietética de sodio ha corregido previamente los defectos de respuesta de los beta-adrenoceptores en individuos hipertensos.
Objetivo del estudio:
- Investigar el efecto de la restricción dietética de sodio en la respuesta vascular y linfocítica beta-adrenérgica en sujetos ancianos.
- Para determinar si una dieta baja en sodio puede corregir los déficits relacionados con la edad en la función beta-adrenérgica.
Principales métodos:
- Se estudiaron 10 sujetos normotensos mayores (56 +/- 2 años) en una dieta alta en sodio (400 meq/día) o baja en sodio (10 meq/día).
- Evaluación de la respuesta vascular a través de la vasodilatación mediada por isoproterenol.
- Se midió la sensibilidad de la adenilil ciclasa de los linfocitos al isoproterenol.
Principales resultados:
- La vasodilatación máxima mediada por isoproterenol se redujo en sujetos de edad avanzada en una dieta alta en sodio en comparación con sujetos más jóvenes.
- Una dieta baja en sodio aumentó significativamente la vasodilatación y la sensibilidad de los linfocitos a la adenilil ciclasa en los ancianos.
- La presión arterial disminuyó en una dieta baja en sodio, con la presión arterial media inversamente correlacionada con la vasodilatación.
Conclusiones:
- Una dieta baja en sodio corrige efectivamente el deterioro de la respuesta vascular y linfocítica beta-adrenérgica asociada con el envejecimiento.
- La modificación de la dieta juega un papel importante en la regulación adrenérgica del tono vascular en los ancianos.
Videos de Conceptos Relacionados
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...